Ohara Pharmaceutical Overview

  • Year Founded
  • 1964

Year Founded

  • Status
  • Private

  • Employees
  • 468

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $69.1M

  • Investors
  • 3

Ohara Pharmaceutical General Information

Description

Manufacturer of prescription medicines intended to address rare and specialized medical conditions. The company develops, manufactures, and distributes pharmaceutical products including treatments for rare diseases, oncology, leukemia, liver related disorders, and selected generics, with activities covering research, clinical development, regulatory compliance, enabling hospitals, healthcare providers, and patients to access reliable medicines that support treatment continuity, medical safety, and affordability within regulated healthcare systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 36 Floor Saint Luke's Tower, 8-1 Akashi-cho
  • Chuo-ku
  • Tokyo, 104-6591
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 36 Floor Saint Luke's Tower, 8-1 Akashi-cho
  • Chuo-ku
  • Tokyo, 104-6591
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ohara Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 30-Jun-2025 $69.1M Completed Clinical Trials - Phase 3
1. Accelerator/Incubator Completed Clinical Trials - Phase 3
To view Ohara Pharmaceutical’s complete valuation and funding history, request access »

Ohara Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A Shares
To view Ohara Pharmaceutical’s complete cap table history, request access »

Ohara Pharmaceutical Patents

Ohara Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025263591-A1 Crystalline form of oral dnmt inhibitor Pending 21-Jun-2024
WO-2025142803-A1 Pharmaceutical composition for oral administration of dnmt inhibitor Inactive 25-Dec-2023
JP-2025122084-A Levodopa sustained release formulation Pending 28-Jul-2022
WO-2024024865-A1 Levodopa sustained release formulation Inactive 28-Jul-2022
JP-7719476-B2 Cbp/catenin inhibitor treatment regimen for liver fibrosis Active 28-Apr-2022
To view Ohara Pharmaceutical’s complete patent history, request access »

Ohara Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ohara Pharmaceutical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
JIC Venture Growth Investments Venture Capital Minority
Regional Medical Revitalization Healthcare Fund Investment Business Corporation Minority
LINK-J Accelerator/Incubator
To view Ohara Pharmaceutical’s complete investors history, request access »

Ohara Pharmaceutical Investments (9)

Ohara Pharmaceutical’s most recent deal was a PE Growth/Expansion with MyDawa for . The deal was made on 30-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MyDawa 30-Apr-2025 PE Growth/Expansion Specialty Retail
Africa Healthcare Network 22-Nov-2023 Later Stage VC Clinics/Outpatient Services
Helium Health 05-Jun-2023 Later Stage VC Medical Records Systems
Revital Healthcare 28-Dec-2021 PE Growth/Expansion Medical Supplies
J-Pharma 11-Aug-2021 Later Stage VC Drug Discovery
You’re viewing 5 of 9 investments. Get the full list »

Ohara Pharmaceutical FAQs

  • When was Ohara Pharmaceutical founded?

    Ohara Pharmaceutical was founded in 1964.

  • Where is Ohara Pharmaceutical headquartered?

    Ohara Pharmaceutical is headquartered in Tokyo, Japan.

  • What is the size of Ohara Pharmaceutical?

    Ohara Pharmaceutical has 468 total employees.

  • What industry is Ohara Pharmaceutical in?

    Ohara Pharmaceutical’s primary industry is Drug Discovery.

  • Is Ohara Pharmaceutical a private or public company?

    Ohara Pharmaceutical is a Private company.

  • What is the current valuation of Ohara Pharmaceutical?

    The current valuation of Ohara Pharmaceutical is .

  • What is Ohara Pharmaceutical’s current revenue?

    The current revenue for Ohara Pharmaceutical is .

  • How much funding has Ohara Pharmaceutical raised over time?

    Ohara Pharmaceutical has raised $69.1M.

  • Who are Ohara Pharmaceutical’s investors?

    JIC Venture Growth Investments, Regional Medical Revitalization Healthcare Fund Investment Business, and LINK-J have invested in Ohara Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process